On-patient medical record and mRNA therapeutics using intradermal microneedles
Source abstract
Abstract
Abstract Medical interventions often require timed series of doses, thus necessitating accurate medical record-keeping. In many global settings, these records are unreliable or unavailable at the point of care, leading to less effective treatments or disease prevention. Here we present an invisible-to-the-naked-eye on-patient medical record-keeping technology that accurately stores medical information in the patient skin as part of microneedles that are used for intradermal therapeutics. We optimize the microneedle design for both a reliable delivery of messenger RNA (mRNA) therapeutics and the near-infrared fluorescent microparticles that encode the on-patient medical record-keeping. Deep learning-based image processing enables encoding and decoding of the information with excellent temporal and spatial robustness. Long-term studies in a swine model demonstrate the safety, efficacy and reliability of this approach for the co-delivery of on-patient medical record-keeping and the mRNA vaccine encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This technology could help healthcare workers make informed decisions in circumstances where reliable record-keeping is unavailable, thus contributing to global healthcare equity.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Spectroscopy Techniques in Biomedical and Chemical Research · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Qin, S. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduct. Target. Ther. 7, 166 (2022).10.1038/s41392-022-01007-w ↗
2. Bhat, B. mRNA therapeutics: beyond vaccine applications. Trends Mol. Med. 27, 923–924 (2021).10.1016/j.molmed.2021.05.004 ↗
3. Barbier, A. J. The clinical progress of mRNA vaccines and. Nat. Biotechnol. 40, 840–854 (2022).10.1038/s41587-022-01294-2 ↗
4. Beck, J. D. mRNA therapeutics in cancer. Mol. Cancer 20, 69 (2021).10.1186/s12943-021-01348-0 ↗
5. Deng, Z. mRNA vaccines: the dawn of a new era of cancer immunotherapy. Front. Immunol. 13, 887125 (2022).10.3389/fimmu.2022.887125 ↗
6. RNActive® Rabies Vaccine (CV7201) in Healthy Adults No. NCT02241135 (US National Library of Medicine, 2018); https://clinicaltrials.gov/study/NCT02241135
7. RNActive®-Derived Therapeutic Vaccine No. NCT00906243 (US National Library of Medicine, 2012); https://clinicaltrials.gov/study/NCT00906243
8. An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) No. NCT03897881 (US National Library of Medicine, 2022); https://clinicaltrials.gov/study/NCT03897881
9. Recommended Vaccinations for Infants and Children, Parent-Friendly Version (Centers for Disease Control and Prevention, 2023); https://www.ncbi.nlm.nih.gov/books/NBK603055/table/ch5.tab1/?report=objectonly
10. Shargel, L. & Yu, A. Applied Biopharmaceutics & Pharmacokinetics 6th edn (McGraw-Hill, 2012).
11. Blaschke, T. F. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu. Rev. Pharmacol. Toxicol. 52, 275–301 (2012).10.1146/annurev-pharmtox-011711-113247 ↗
12. Baryakova, T. H. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat. Rev. Drug Discov. 22, 387–409 (2023).10.1038/s41573-023-00670-0 ↗
13. Martin, L. R. The challenge of patient adherence. Ther. Clin. Risk Manag. 1, 189–199 (2005).
14. Bobo, F. T. Child vaccination in sub-Saharan Africa: increasing coverage addresses inequalities. Vaccine 40, 141–150 (2022).10.1016/j.vaccine.2021.11.005 ↗
15. Global Health Security: Immunization (Centers for Disease Control and Prevention, 2014); https://archive.cdc.gov/#/details?url=https://www.cdc.gov/globalhealth/security/immunization.htm
16. Adetokunboh, O. Missed opportunities for vaccination in Africa. Curr. Opin. Immunol. 71, 55–61 (2021).10.1016/j.coi.2021.05.002 ↗
17. Rainey, J. J. Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: findings from a systematic review of the published literature, 1999–2009. Vaccine 29, 8215–8221 (2011).10.1016/j.vaccine.2011.08.096 ↗
18. Jalloh, M. F. Assessment of VaxTrac electronic immunization registry in an urban district in Sierra Leone: implications for data quality, defaulter tracking, and policy. Vaccine 38, 6103–6111 (2020).10.1016/j.vaccine.2020.07.031 ↗
19. Katib, A. A prototype of a novel cell phone application for tracking the vaccination coverage of children in rural communities. Comput. Methods Prog. Biomed. 122, 215–228 (2015).10.1016/j.cmpb.2015.08.008 ↗
20. Get a SMART Health Card for your COVID-19 vaccination. SMART Health (2021); https://smarthealth.cards/en/
21. Xiao, C. & Yu, A. Medical Smart Card System for Patient Record Management (Open Computing Facility, University of California, Berkeley, 2009); https://www.ocf.berkeley.edu/~step/White_Paper/Xiao_Yu.pdf
22. Tanne, J. H. FDA approves implantable chip to access medical records. Br. Med. J. 329, 1064 (2004).10.1136/bmj.329.7474.1064 ↗
23. Charnock, V. Electronic healthcare records and data quality. Health Info. Lib. J. 36, 91–95 (2019).10.1111/hir.12249 ↗
24. Harman, L. B., Flite, C. A. & Bond, K. Electronic health records: privacy, confidentiality, and security. Virtual Mentor. 14, 712–719 (2012).10.1001/virtualmentor.2012.14.9.stas1-1209 ↗
25. Keshta, I. Security and privacy of electronic health records: concerns and challenges. Egypt. Inform. J. 22, 177–183 (2021).10.1016/j.eij.2020.07.003 ↗
26. Ozair, F. F. Ethical issues in electronic health records: a general overview. Perspect. Clin. Res. 6, 73–76 (2015).10.4103/2229-3485.153997 ↗
27. Meetoo, D. Smart tattoo: technology for monitoring blood glucose in the future. Br. J. Nurs. 28, 110–115 (2019).10.12968/bjon.2019.28.2.110 ↗
28. Mchugh, K. J. Biocompatible near-infrared quantum dots delivered to the skin by microneedle patches record vaccination. Sci. Transl. Med. 11, eaay7162 (2019).10.1126/scitranslmed.aay7162 ↗
29. Baranov, M. V. Modulation of immune responses by particle size and shape. Front. Immunol. 11, 607945 (2021).10.3389/fimmu.2020.607945 ↗
30. Choi, H. S. Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165–1170 (2007).10.1038/nbt1340 ↗
31. Longmire, M. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3, 703–717 (2008).10.2217/17435889.3.5.703 ↗
32. Kolarsick, P. A. Anatomy and physiology of the skin. J. Dermatol. Nurses Assoc. 3, 203–213 (2011).10.1097/JDN.0b013e3182274a98 ↗
33. Lunney, J. K. Importance of the pig as a human biomedical model. Sci. Transl. Med. 13, eabd5758 (2021).10.1126/scitranslmed.abd5758 ↗
34. Ety Navon, O. M. Color image segmentation based on adaptive local thresholds. Image Vis. Comput. 23, 69–85 (2005).10.1016/j.imavis.2004.05.011 ↗
35. Teja, R. Error correction and detection codes. Electronics Hub https://www.electronicshub.org/error-correction-and-detection-codes/ (2024).
36. Muller, D. E. Application of Boolean algebra to switching circuit design and to error detection. Trans. I.R.E. Prof. Group Electron. Comput. EC-3, 6–12 (1954).10.1109/IREPGELC.1954.6499441 ↗
37. Reed, I. A class of multiple-error-correcting codes and the decoding scheme. Trans. I.R.E. Prof. Group Inf. Theory 4, 38–49 (1954).10.1109/TIT.1954.1057465 ↗
38. Ronneberger, O., Fischer, P. & Brox, T. U-Net: convolutional networks for biomedical image segmentation. In Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015. Lecture Notes in Computer Science (eds Navab, N. et al.) Vol. 9351, 234–241 (Springer, Cham, 2015); https://doi.org/10.1007/978-3-319-24574-4_2810.1007/978-3-319-24574-4_28 ↗
39. Krizhevsky, A. ImageNet classification with deep convolutional neural networks. Adv. Neural Inf. Process. Syst. 60, 84–90 (2012).
40. Seaton, M. Porcine models of cutaneous wound healing. ILAR J. 56, 127–138 (2015).10.1093/ilar/ilv016 ↗
41. Koster, M. I. Making an epidermis. Ann. N. Y. Acad. Sci. 1170, 7–10 (2009).10.1111/j.1749-6632.2009.04363.x ↗
42. Etra, J. W. & Skin, A. Rejection grading system for vascularized composite allotransplantation in a preclinical large animal model. Transplantation 103, 1385–1391 (2019).10.1097/TP.0000000000002695 ↗
43. vander Straeten, A. et al. A microneedle vaccine printer enables decentralized manufacturing of thermostable COVID-19 mRNA vaccines. Nat. Biotechnol. 42, 510–517 (2024).10.1038/s41587-023-01774-z ↗
44. Kim, E. Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine 55, 102743 (2020).10.1016/j.ebiom.2020.102743 ↗
45. Koh, K. J. Formulation, characterization and evaluation of mRNA-loaded dissolvable polymeric microneedles (RNApatch). Sci. Rep. 8, 11842 (2018).10.1038/s41598-018-30290-3 ↗
46. Chen, W. Microneedles as a delivery system for gene therapy. Front. Pharm. 7, 137 (2016).10.3389/fphar.2016.00137 ↗
47. de Mello, J. C., Wittmann, H. F. & Friend, R. H. An improved experimental determination of external photoluminescence quantum efficiency. Adv. Mater. 9, 230–232 (1997).10.1002/adma.19970090308 ↗
48. Fenton, O. Customizable lipid nanoparticle materials for the delivery of siRNAs and mRNAs. Angew. Chem. Int. Ed. 57, 13582–13586 (2018).10.1002/anie.201809056 ↗
49. Hassett, K. J. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1–11 (2019).10.1016/j.omtn.2019.01.013 ↗
50. Sabnis, S. Amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. 26, 1509–1519 (2018).10.1016/j.ymthe.2018.03.010 ↗
51. Lewinski, N., Colvin, V. & Drezek, R. Cytotoxicity of nanoparticles. Small 4, 26–49 (2008).10.1002/smll.200700595 ↗
52. Hon, T. et al. Highly accurate long-read HiFi sequencing data for five complex genomes. Sci. Data 7, 399 (2020).10.1038/s41597-020-00743-4 ↗